4//SEC Filing
COLLINS MORTON 4
Accession 0001055726-19-000037
CIK 0001055726other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 3:56 PM ET
Size
11.0 KB
Accession
0001055726-19-000037
Insider Transaction Report
Form 4
COLLINS MORTON
Director
Transactions
- Exercise/Conversion
Common Stock
2019-05-11+8,170→ 168,130 total - Exercise/Conversion
Restricted Stock Unit
2019-05-11−8,170→ 0 total→ Common Stock (8,170 underlying)
Holdings
- 6,450(indirect: By Spouse)
Common Stock
- 64,750(indirect: By Trust)
Common Stock
- 4,500(indirect: By Trust)
Common Stock
- 50,000(indirect: By IRA)
Common Stock
- 6,650(indirect: By Spouse)
Common Stock
- 64,750(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested with respect to 100% of the shares on May 11, 2019.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeother
Related Parties
1- filerCIK 0001238716
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 3:56 PM ET
- Size
- 11.0 KB